Everything below concerns research chemical. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-05-15. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Derived from published structure. |
| Molecular weight | 437.94 g/mol | Calculated value. |
| Appearance | White to off-white solid | Typical for purified research samples. |
| Solubility | DMSO, ethanol; low in water | Class: poorly water-soluble. |
| Typical storage | -20 °C, desiccated, protected from light | Limits degradation. |
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
Afterwards, Larter commented on future producing endeavors during an interview about Resident Evil: Extinction: "I definitely have many ideas and different avenues that I want to take as my career goes on." In 2005, she appeared in Confess, an independent political thriller, and had a role in the romantic comedy A Lot Like Love, starring Amanda Peet and Ashton Kutcher. Also in 2005, she returned to living in Los Angeles.
== Structure == Type III collagen is synthesized by cells as a pre-procollagen; the human preproα1(III) chain is 1466 amino acids long, comprising an N-terminal signal peptide (residues 1–23), an N-terminal propeptide, the roughly 1000-residue triple-helical domain, and a C-terminal propeptide. The signal peptide is cleaved off producing a procollagen molecule. Three identical type III procollagen chains come together at the carboxy-terminal ends, and the structure is stabilized by the formation of disulphide bonds. Each individual chain folds into a left-handed helix and the three chains are then wrapped together into a right-handed superhelix, the triple helix. Prior to assembling the super-helix, each monomer is subjected to a number of post-translational modifications that occur while the monomer is being translated. First, on the order of 145 prolyl residues of the 239 in the triple-helical domain are hydroxylated to 4-hydroxyproline by prolyl-4-hydroxylase. Second, some of the lysine residues are hydroxylated or glycosylated, and some lysine as well as hydroxylysine residues undergo oxidative deamination catalysed by lysyl oxidase. Other post-translational modifications occur after the triple helix is formed. The large globular domains from both ends of the molecule are removed by C- and amino(N)-terminal-proteinases to generate triple-helical type III collagen monomers called tropocollagen. In addition, crosslinks form between certain lysine and hydroxylysine residues.
=== Origin === Natural sausage casings are made from the sub-mucosa of the small intestine of meat animals, a layer of the intestine that consists mainly of naturally occurring collagen. In Western European cuisine and Chinese cuisine, most casings come from pigs, but elsewhere the intestines of sheep, goats, cattle and sometimes horses are also used. To prepare the intestines as casings, they are flushed, scraped and cleaned with water and salt by hand or with machinery; today they are primarily machine-cleaned. The outer fat and the inner mucosa lining are removed during processing. They are salted to lower the water activity (which inhibits microbial growth) and preserve the casing. Natural casings have been used in the production of meat specialties for centuries and have remained virtually unchanged in function, appearance, and composition. US and EU organic food regulations only allow natural casings, which can be derived from non-organically raised animals as there are no large-scale slaughter plants which handle and process only organic animals and sell their casings as certified organic casings. As a result, all large-scale natural casing companies buy casings from around the world and send them on to be graded and packaged. There are four primary animal genera which are used to manufacture natural casings (although all mammals raised for meat could potentially be used to produce natural casing): cows, pigs, lamb and sheep.
Sources: en.wikipedia.org
Cairnes School of Business & Economics. Several new buildings were constructed on the university campus in the 1970s and were designed by architects Scott Tallon Walker. The 1990s also saw considerable development, including the conversion of an old munitions factory into a student centre. Under the early 21st-century Presidency of Iognáid G. Ó Muircheartaigh, the university announced details of plans to make the university a "campus of the future" at a cost of around €400 million. Ó Muircheartaigh's successor James J. Browne continued and implemented that plan. Under the Universities Act 1997, the name of University College, Galway, was changed to National University of Ireland, Galway (NUI Galway), and it became a university in its own right, as a constituent university of the National University of Ireland (NUI). The university had hoped to change its name to University of Galway, but had received legal advice that this was not possible under the provisions of the Act. Visiting the university in 2003, on what was to be his last visit to Ireland, Nelson Mandela condemned U.S. foreign policy and received an honorary doctorate from the NUI Chancellor, Garret FitzGerald. 21st-century developments include a state-of-the-art University Sports Centre (Ionad Spóirt), Áras Moyola, J.E. Cairnes School of Business & Economics, the Alice Perry Engineering Building, the BioSciences Research Building, the Life Course Institute, the Lambe Institute and the O'Donoghue Centre for Drama, Theatre and Performance, and the Human Biology Building.
== Threats == It was overexploited in the twentieth century and was classed as a vulnerable species in 1998. This reached a level in the early twenty-first century where most trees of a size for commercial use had been cut down. As a consequence, other species of Dalbergia started to be exploited in its place.
==== Monetary policy ==== Since Castillo's victory in the first electoral round, the Sol has faced a precipitous fall in value against the dollar, due to fears of inflation and expropriations. As of 23 September 2021, the Sol had lost 12% of its value since the start of the year, making Peru's currency one of the worst performers among emerging markets. Castillo has sought to calm the markets by keeping Julio Velarde as the head of the Central Bank. During a speech before the OAS assembly, Castillo stated that his government is not communist and that he wouldn't expropriate anyone. Castillo stated that he didn't come to scare away investment, and invited big businesses to come to the country. Following Bellido's threat to nationalize the Camisea gas fields, the sol plunged once again. Afterward, Castillo replaced the Bellido cabinet with the Vásquez cabinet, which many have seen as a shift towards a more centrist administration. Following the new cabinet, the Sol began to recover its value, reaching a 10-week high as of 13 October 2021. However, after Castillo asked Congress to nationalize the Camisea gas fields, the Sol began to fall in value once again. On 9 November 2021, the Bank of America warned that almost all of Peru's inflation indicators are on red alert. They claimed that Peru's expectations "are set to exceed the upper limit of 3% of the Central Bank's target range of a two-year term." The Bank of America suggested that the Central Bank will have to tighten monetary policy.
Sources: en.wikipedia.org
The military responded with force and in the ensuing crossfire some 120 people lost their lives, including most of the guerrillas (several high-ranking operatives among them) and 12 Supreme Court Judges.[1] Both sides blamed each other for the bloodbath, which marked the end of Betancur's peace process.[2] Meanwhile, individual FARC members initially joined the UP leadership in representation of the guerrilla command, though most of the guerrilla's chiefs and militiamen did not demobilize nor disarm, as that was not a requirement of the process at that point in time. Tension soon significantly increased, as both sides began to accuse each other of not respecting the cease-fire. According to historian Daniel Pecáut, the creation of the Patriotic Union took the guerrillas' political message to a wider public outside of the traditional communist spheres of influence and led to local electoral victories in regions such as Urabá and Antioquia, with their mayoral candidates winning 23 municipalities and their congressional candidates gaining 14 seats (five in the Senate, nine in the lower Chamber) in 1988. Pecáut stated that new recruits entered the guerrilla army and its urban militia units during this period, and that the FARC continued to carry out kidnappings and target regional politicians for assassination.
The dragon blood tree has an upturned, densely packed, umbrella-shaped crown. This evergreen species is named after its dark red resin, which is known as "dragon's blood". Unlike most monocot plants, Dracaena displays secondary growth; D. cinnabari even has growth zones resembling tree rings found in dicot tree species. Along with other arborescent Dracaena species it has a distinctive growth habit called "dracoid habitus". Its leaves are found only at the ends of its youngest branches and are shed every three or four years as new leaves simultaneously mature. Branching tends to occur when the growth of the terminal bud is stopped, through either flowering or traumatic events (e.g. herbivory). The tree measures up to 9 m (30 ft) in height and 12 m (39 ft) across the crown, and the trunk reaches up to 1.5 m (4 ft 11 in) DBH. The fruits of D. cinnabari are small fleshy berries containing between one and four seeds. As they develop they turn from green to black, and then become orange when ripe. The berries are eaten by birds (e.g. Onychognatus species) and thereby dispersed. The seeds are 4–5 mm (0.16–0.20 in) in diameter and weigh on average 68 mg. The berries exude a deep red resin colloquially known as dragon's blood. Like other monocotyledons such as palms, the dragon's blood tree grows from the tip of the stem, with the long, stiff leaves borne in dense rosettes at the end. It branches at maturity to produce an umbrella-shaped crown, with leaves that measure up to 60 cm (24 in) long and 3 cm (1.2 in) wide. The trunk and branches of D.
There is broad scientific consensus that the acids DHA and EPA (both of which are highly prevalent in seafood) are beneficial to neurodevelopment and cognition, especially at young ages. The United Nations' Food and Agriculture Organization has described fish as "nature's superfood". Seafood consumption is associated with improved neurodevelopment during pregnancy and early childhood. Fish consumption is associated with a decreased risk of dementia, lung cancer, and stroke, as well as a more tenuous link to reduced mortality from coronary heart disease. A 2020 umbrella review concluded that fish consumption reduces all-cause mortality, cancer, cardiovascular disease, stroke, and other outcomes, while suggesting that two to four servings per week is generally safe. However, two other umbrella reviews found no statistically significant association between fish consumption and cancer risks, and have cautioned researchers when it comes to interpreting this reported association as the quality of evidence is low. The parts of fish containing essential fats and micronutrients, often cited as the primary health benefits of eating seafood, are frequently discarded in the developed world. Micronutrients including calcium, iodine, potassium, selenium, and zinc are found in their highest concentrations in the head, intestines, bones, and scales of fish. Government recommendations promote moderate consumption of fish.
Sources: en.wikipedia.org
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.
No. SR9009 targets the nuclear receptors REV-ERBα and REV-ERBβ, not the androgen receptor. This mechanism differs from selective androgen receptor modulators and from exercise mimetics that act on PPARδ.
Published evidence is mainly preclinical, using cell cultures and animal models. Controlled human trials are not well documented in the public literature. Claims about human performance or health effects therefore remain unsupported by robust clinical data.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.